HK1159104A1 - 慢性腎功能衰竭處置劑 - Google Patents

慢性腎功能衰竭處置劑

Info

Publication number
HK1159104A1
HK1159104A1 HK11113639.7A HK11113639A HK1159104A1 HK 1159104 A1 HK1159104 A1 HK 1159104A1 HK 11113639 A HK11113639 A HK 11113639A HK 1159104 A1 HK1159104 A1 HK 1159104A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic agent
renal failure
chronic renal
chronic
failure
Prior art date
Application number
HK11113639.7A
Other languages
English (en)
Inventor
松田二子
伊關克彥
車谷元
宫本美津子
Original Assignee
東麗株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41570369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1159104(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 東麗株式會社 filed Critical 東麗株式會社
Publication of HK1159104A1 publication Critical patent/HK1159104A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
HK11113639.7A 2008-07-23 2011-12-16 慢性腎功能衰竭處置劑 HK1159104A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008190085 2008-07-23
PCT/JP2009/063153 WO2010010909A1 (ja) 2008-07-23 2009-07-23 慢性腎不全処置剤

Publications (1)

Publication Number Publication Date
HK1159104A1 true HK1159104A1 (zh) 2012-07-27

Family

ID=41570369

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113639.7A HK1159104A1 (zh) 2008-07-23 2011-12-16 慢性腎功能衰竭處置劑

Country Status (13)

Country Link
US (1) US8575175B2 (zh)
EP (1) EP2305653B9 (zh)
JP (1) JP5609643B2 (zh)
KR (1) KR101587071B1 (zh)
CN (1) CN102105453B (zh)
BR (1) BRPI0916282B8 (zh)
CA (1) CA2730599C (zh)
ES (1) ES2532858T3 (zh)
HK (1) HK1159104A1 (zh)
MX (1) MX2011000897A (zh)
MY (1) MY163762A (zh)
PL (1) PL2305653T3 (zh)
WO (1) WO2010010909A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2447254T (pt) 2009-06-26 2018-01-04 Nippon Shinyaku Co Ltd Cristais
WO2011024874A1 (ja) * 2009-08-26 2011-03-03 日本新薬株式会社 塩基付加塩
ES2693622T3 (es) 2011-01-13 2018-12-13 SciPharm S.à r.l. Método para mejorar el injerto de células madre hematopoyéticas
MX2016010892A (es) * 2014-02-26 2016-11-17 Nippon Zoki Pharmaceutical Co Agente para suprimir el progreso de o para mejorar la enfermedad renal cronica.
CN109563055B (zh) * 2016-07-29 2021-12-24 成都苑东生物制药股份有限公司 氨基吡嗪类化合物或盐、异构体、其制备方法及用途
AU2017341020B2 (en) 2016-10-06 2021-10-28 Daiichi Sankyo Company,Limited Urea derivative
AR112842A1 (es) 2017-09-28 2019-12-18 Nippon Shinyaku Co Ltd Cristal de pirazina
MX2020004962A (es) 2017-11-16 2020-08-27 Nippon Shinyaku Co Ltd Preparacion de liberacion controlada.
EP3741376A4 (en) 2017-12-15 2021-09-22 Green Cross WellBeing Corporation PROBIOTICS TO INHIBIT AND PREVENT THE DEVELOPMENT OF KIDNEY DISEASES AND COMPOSITIONS TO INHIBIT AND PREVENT THE EVOLUTION OF KIDNEY DISEASES INCLUDING THEM

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH093973A (ja) 1995-06-26 1997-01-07 Kubota Corp 作業機械の走行装置
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
JPH1121843A (ja) 1997-07-08 1999-01-26 Nippon Kaiyo Consultant Kk 海水循環方法
JP3181859B2 (ja) 1997-07-08 2001-07-03 三菱電機株式会社 電力変換装置
AUPP003297A0 (en) * 1997-10-27 1997-11-20 Fujisawa Pharmaceutical Co., Ltd. 4,5-diaryloxazole compounds
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives
JP2000067748A (ja) 1998-08-26 2000-03-03 Matsushita Electronics Industry Corp カラー陰極線管の製造方法
US6335459B1 (en) 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
US20030036513A1 (en) 1999-02-16 2003-02-20 Yurkow Edward J. Method for treating cancer
WO2000067748A1 (fr) 1999-05-10 2000-11-16 Toray Industries, Inc. Remèdes à l'insuffisance rénale
JP3858521B2 (ja) 1999-06-28 2006-12-13 松下電器産業株式会社 移動体識別装置
AUPQ253199A0 (en) 1999-08-30 1999-09-23 Fujisawa Pharmaceutical Co., Ltd. Non-prostanoid prostaglandin I2-agonist
DE60102106T2 (de) 2000-08-03 2004-07-15 Pfizer Products Inc., Groton Diazacyclooctanverbindungen und ihre therapeutische Verwendung
TWI316055B (zh) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
US7104566B2 (en) 2002-04-25 2006-09-12 Delphi Technologies, Inc. Airbag module and cover arrangement
JP4340111B2 (ja) 2003-08-08 2009-10-07 大成化工株式会社 ポンプ容器
CN1917883B (zh) 2003-12-16 2011-05-11 联合治疗公司 曲前列环素在制备改善肾功能的药物中的用途
PL364348A1 (en) * 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent
JP4694900B2 (ja) 2005-06-28 2011-06-08 株式会社ディスコ レーザー加工方法
ES2451627T3 (es) * 2005-07-08 2014-03-28 Toray Industries, Inc. Agente terapéutico y método de tratamiento para mejorar uremia
CN104761509A (zh) 2008-02-28 2015-07-08 日本新药株式会社 纤维化抑制剂
EP2384196B1 (en) 2008-12-30 2017-09-13 Johansson, Pär Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
PT2447254T (pt) 2009-06-26 2018-01-04 Nippon Shinyaku Co Ltd Cristais

Also Published As

Publication number Publication date
US20110178103A1 (en) 2011-07-21
US8575175B2 (en) 2013-11-05
ES2532858T9 (es) 2015-07-03
BRPI0916282B1 (pt) 2019-10-29
EP2305653A4 (en) 2012-05-16
CN102105453A (zh) 2011-06-22
EP2305653B9 (en) 2015-06-24
BRPI0916282B8 (pt) 2021-05-25
MY163762A (en) 2017-10-31
JPWO2010010909A1 (ja) 2012-01-05
MX2011000897A (es) 2011-03-30
PL2305653T3 (pl) 2015-08-31
JP5609643B2 (ja) 2014-10-22
CA2730599C (en) 2016-09-13
KR20110036572A (ko) 2011-04-07
EP2305653A1 (en) 2011-04-06
EP2305653B1 (en) 2015-03-04
KR101587071B1 (ko) 2016-01-20
CA2730599A1 (en) 2010-01-28
ES2532858T3 (es) 2015-04-01
CN102105453B (zh) 2016-05-25
WO2010010909A1 (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
HK1159104A1 (zh) 慢性腎功能衰竭處置劑
EP2258395A4 (en) THERAPEUTIC AGENT FOR A FIBROUS LUNG
HK1200697A1 (zh) 搔癢症治療藥
EP2122343A4 (en) MONITOR RENAL
EP2320907A4 (en) THERAPEUTIC COMPOUNDS
EP2211620A4 (en) THERAPEUTIC COMPOUNDS
HK1145465A1 (en) Hemodialysis apparatus
GB0815696D0 (en) Dual model approach for boiler section cleanlines calculation
EP2238063A4 (en) SECURING SYSTEM FOR LIFT
HK1199059A1 (zh) 治療腎功能衰竭的選擇性細胞療法
PL2144966T3 (pl) Struktura wielowarstwowa
PL2250280T3 (pl) Terapeutyczne zastosowania gelsoliny w niewydolności nerek
EP2268285A4 (en) THERAPEUTIC COMPOUNDS
HK1150023A1 (en) Trans-clomiphene for metabolic syndrome
GB0806794D0 (en) Therapeutic compounds
GB0716532D0 (en) Therapeutic compounds
AP3125A (en) Failure mechanism for mechanical connection
GB0813740D0 (en) Therapeutic compounds
EP2164324A4 (en) THERAPEUTIC COMPOUNDS
GB0804755D0 (en) Therapeutic compounds
EP2185568A4 (en) THERAPEUTIC COMPOUNDS
EP2138184A4 (en) PROPHYLACTIC AGENT FOR RENAL FAILURE
GB0702862D0 (en) Therapeutic compounds
ZA201003835B (en) Therapeutic agent for ulcer
GB0708188D0 (en) Therapeutic compounds